#Phase1Trial reports positive results for a #brain -protective #immunotherapy in early #AlzheimersDisease.
Immune therapy for Alzheimer's disease takes a step forward – BioNews Central
Phase 1 trial reports positive results for a brain-protective immunotherapy in early Alzheimer's disease. ...
sbee.link
August 4, 2026 at 4:49 PM
#Phase1Trial reports positive results for a #brain -protective #immunotherapy in early #AlzheimersDisease.
🩺💡Today’s clinical questions!
Swipe to see the answers and explanations!
#Engasertib #AKTInhibitor #AKTPathway #BreastCancer #Oncology #CancerResearch #ClinicalTrials #Phase1Trial #NEJM #MedicalEducation #OncologyEducation #MedEd #CancerCare #AdverseEvents #OncTwitter #HemeOnc #HEMEHUB
Swipe to see the answers and explanations!
#Engasertib #AKTInhibitor #AKTPathway #BreastCancer #Oncology #CancerResearch #ClinicalTrials #Phase1Trial #NEJM #MedicalEducation #OncologyEducation #MedEd #CancerCare #AdverseEvents #OncTwitter #HemeOnc #HEMEHUB
June 25, 2026 at 2:00 AM
🩺💡Today’s clinical questions!
Swipe to see the answers and explanations!
#Engasertib #AKTInhibitor #AKTPathway #BreastCancer #Oncology #CancerResearch #ClinicalTrials #Phase1Trial #NEJM #MedicalEducation #OncologyEducation #MedEd #CancerCare #AdverseEvents #OncTwitter #HemeOnc #HEMEHUB
Swipe to see the answers and explanations!
#Engasertib #AKTInhibitor #AKTPathway #BreastCancer #Oncology #CancerResearch #ClinicalTrials #Phase1Trial #NEJM #MedicalEducation #OncologyEducation #MedEd #CancerCare #AdverseEvents #OncTwitter #HemeOnc #HEMEHUB
🚨New data on inhaled siRNA therapies for respiratory viruses!
ascpt.onlinelibrary.wiley.com/doi/10.1111/...
#COVID19 #SARSCoV2 #Antivirals #ClinicalTrials #RNAtherapy #Phase1Trial
ascpt.onlinelibrary.wiley.com/doi/10.1111/...
#COVID19 #SARSCoV2 #Antivirals #ClinicalTrials #RNAtherapy #Phase1Trial
Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified siRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects
Severe acute respiratory syndrome caused by the coronavirus (SARS-CoV-2) in the COVID-19 pandemic has highlighted the need for effective treatments, as rapid viral mutations complicate therapeutic de....
ascpt.onlinelibrary.wiley.com
March 28, 2025 at 1:00 PM
🚨New data on inhaled siRNA therapies for respiratory viruses!
ascpt.onlinelibrary.wiley.com/doi/10.1111/...
#COVID19 #SARSCoV2 #Antivirals #ClinicalTrials #RNAtherapy #Phase1Trial
ascpt.onlinelibrary.wiley.com/doi/10.1111/...
#COVID19 #SARSCoV2 #Antivirals #ClinicalTrials #RNAtherapy #Phase1Trial
Sumitomo Pharma & NIBIOHN collaborate on universal flu vaccine Phase 1 trials. 🌍💉 #協力研究 #インフルエンザ総合投与 #Phase1Trial https://fefd.link/E6Vfn
February 3, 2025 at 6:46 AM
Sumitomo Pharma & NIBIOHN collaborate on universal flu vaccine Phase 1 trials. 🌍💉 #協力研究 #インフルエンザ総合投与 #Phase1Trial https://fefd.link/E6Vfn
##StemCell derived ##ChimericAntigenReceptor (CAR) ##NaturalKillerCells show potential for treating ##BCellLymphomas and could make future cellular ##immunotherapies less expensive and more accessible to patients.
##Phase1Trial
##Phase1Trial
New cellular immunotherapy approach shows promise for B-cell lymphoma – BioNews Central
Stem-cell-derived chimeric antigen receptor (CAR) natural killer cells show potential for treating B-cell lymphomas and could make future cellular immunotherapies less expensive and more accessible to patients. ...
sbee.link
January 15, 2025 at 1:02 PM
##StemCell derived ##ChimericAntigenReceptor (CAR) ##NaturalKillerCells show potential for treating ##BCellLymphomas and could make future cellular ##immunotherapies less expensive and more accessible to patients.
##Phase1Trial
##Phase1Trial